Workflow
昊帆生物(301393.SZ)发布上半年业绩,归母净利润7588.48万元,增长15.31%
HIGHFINEHIGHFINE(SZ:301393) 智通财经网·2025-08-28 10:21

Core Viewpoint - Haofan Bio (301393.SZ) reported a revenue of 270 million yuan for the first half of 2025, reflecting a year-on-year growth of 20.10% [1] - The net profit attributable to shareholders of the listed company was 75.8848 million yuan, representing a year-on-year increase of 15.31% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 62.0004 million yuan, showing a year-on-year growth of 4.58% [1] - The basic earnings per share stood at 0.71 yuan [1] Financial Performance - Revenue for the first half of 2025 reached 270 million yuan, up 20.10% compared to the previous year [1] - Net profit attributable to shareholders increased to 75.8848 million yuan, a rise of 15.31% year-on-year [1] - Net profit after deducting non-recurring items was 62.0004 million yuan, marking a 4.58% increase from the previous year [1] - Basic earnings per share were reported at 0.71 yuan [1]